SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the H.C. Wainwright 1st Annual Mental Health Conference. The conference is taking place in-person at the Lotte New York Palace Hotel and virtually on June 27, 2022. Details to access the presentation are as follows:Read more at globenewswire.com
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.